hVIVO (OPORF) GF Value Rank : 0 (As of Dec. 12, 2024)

View and export this data going back to 2020. Start your Free Trial

What is hVIVO GF Value Rank?

hVIVO has the GF Value Rank of 0.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

hVIVO GF Value Rank Related Terms

Thank you for viewing the detailed overview of hVIVO's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

hVIVO Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » hVIVO PLC (OTCPK:OPORF) » Definitions » GF Value Rank

Comparable Companies

Traded in Other Exchanges

ORPH:UK HVO:UK CRO:Germany

Address

42, New Road, Queen Mary Bioenterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.hvivo.com

hVIVO PLC is a European-focused, rare, and orphan drug consulting services platform. The principal activity of the Group is that of a rapidly growing specialist CRO pharmaceutical services company, which involves the testing of vaccines and antivirals using human-challenge clinical trials. The group is also engaged in Venn Life Sciences' Clinical Research Division, providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.

hVIVO Headlines

From GuruFocus

Full Year 2023 hVIVO PLC Analyst Briefing Transcript

By GuruFocus Research • 04-12-2024

Half Year 2024 hVIVO PLC Investor Presentation Transcript

By GuruFocus Research • 09-11-2024

Open Orphan plc Announces �3m COVID-19 Challenge Virus Manufacturing Contract

By Business Wire Business Wire • 05-10-2021

Ethics Approval Granted for Open Orphan's COVID-19 Human Challenge Study Model

By Business Wire Business Wire • 02-17-2021

Half Year 2023 hVIVO PLC Earnings Call Transcript

By GuruFocus Research • 02-14-2024